Ken Fisher acquired 21.8 Thousand Celldex Therapeutics shares worth $840 Thousand. That's 0.00% of their equity portfolio (698th largest holding). The first Celldex Therapeutics trade was made in Q3 2022. Since then Ken Fisher bought shares one more times and sold shares on two occasions. The stake costed the investor $668 Thousand, netting the investor a gain of 26% so far.